FRASER BROOKES LIMITEDActive

Company number 06490636Private limited companyIncorporated 2008

Key figures

£892,298+27.0%
Net assets 2025/26
+11.0%
Average annual growth 2020/21–2025/26
0250 k500 k750 k1 m2020/212021/222022/232023/242024/252025/26

Like most small UK companies, FRASER BROOKES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand136,581293,485187,506119,266131,938
Total assets629,354769,746591,463776,674968,586
Total liabilities44,02739,76983,46273,87876,288
Net assets / total equity585,327729,977508,001702,796892,298
Average number of employees1010101010

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: FRASER BROOKES LIMITED

Company

FRASER BROOKES LIMITED is a private limited company registered with Companies House under company number 06490636. It was incorporated on 1 Feb 2008. Its status is active. The registered office is in Chester (CH4). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files small company accounts (filleted). Net assets were £892,298, up 27% on the previous year. Cash at bank and in hand was £131,938. Total assets were £968,586 and total liabilities £76,288. The company had an average of 10 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 4 Feb 2027.